We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Iridium Electrode Generates Therapeutic Nitric Oxide from Thin Air

By HospiMedica International staff writers
Posted on 12 Aug 2015
Print article
Image: The inline nitric oxide (NO) generator (Photo courtesy of Brian Wilson, MGH Photography Department).
Image: The inline nitric oxide (NO) generator (Photo courtesy of Brian Wilson, MGH Photography Department).
A lightweight, portable device could provide effective treatment of pulmonary hypertension by generating nitric oxide (NO), according to a new study.

Researchers at Massachusetts General Hospital (MGH; Boston, MA, USA) developed two generators—an offline and an inline version—that can serve as a simple and economical method of producing pure NO from air. The offline generator can be used to store NO, while the inline generator can be placed directly on the inspiratory line of a mechanical ventilator or anesthesia machine for bedside or portable use. Both use pulsed electrical discharges to produce therapeutic range NO (5 to 80 ppm) at gas flow rates of 0.5–5 L/min, but also other gas mixtures containing up to 90% O2 and 10% N2.

Potentially toxic gases such as nitrogen dioxide (NO2) and ozone (O3), as well as metal fragments from the electrode are removed using a calcium hydroxide scavenger. Further testing revealed that an iridium spark electrode produced the lowest ratio of NO2/NO. In in-vivo tests on lambs with acute pulmonary hypertension showed that breathing the electrically generated NO caused pulmonary vasodilation and reduced pulmonary arterial pressure and vascular resistance index. Both offline and inline systems delivered therapeutic levels of NO for up to 10 days. The study was published in the July 1, 2015, issue of Science Translational Medicine.

“NO therapy is very expensive, and current systems use gas delivered in heavy tanks, making ambulatory treatment impractical. Our new system can economically make NO from the nitrogen and oxygen in the air using only small amounts of electric power,” said lead author Warren Zapol, MD, director of the MGH Anesthesia Center for Critical Care Research. “This device could enable trials of NO to treat patients with chronic lung diseases and certain kinds of heart failure and would make NO therapy available in parts of the world that don’t have the resources that are currently required.”

NO is a ubiquitous signaling molecule that is crucial for the control of blood pressure, blood flow, and other vital bodily functions. NO is also a powerful vasodilator with a short half-life of a few seconds, which works by signaling the smooth muscle surrounding blood vessel endothelium to relax, thus resulting in vasodilation and increasing blood flow. Inhalation of NO has been found to be an effective therapy for treating pulmonary hypertension in adults and pulmonary hypertension of the newborn (PPHN).

Related Links:

Massachusetts General Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Heart-Lung Machine
HL 40

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.